什么是后生元？燕教授为何押注这一赛道？ 后生元(Postbiotics)是指益生菌经灭活处理后释放的有益代谢物(如短链脂肪酸、细菌素、胞外多糖等)， 具有高稳定性、强安全性、无需冷链、耐胃酸等优势，尤其适合儿童、孕妇及肠胃敏感人群长期使用。 燕教授联合科研团队，精选高活性后生元复合配方，率先应用于口腔护理产品中，有效平衡口腔菌群、 抑制有害菌、修复黏膜屏障，获得用户广泛认可。 如今，这一技术正式迈向"内服"新阶段。燕教授后生元闪释粉采用创新闪释技术，开袋即溶，无需冲 泡，入口3秒快速吸收。产品以高纯度后生元为核心，协同多种植物活性成分，靶向调节肠道微生态， 增强身体防护盾，帮助用户远离"肝"扰，夯实健康根基。 当"益生菌"已成过去式，"后生元"正成为健康新风口。作为国内率先系统布局后生元技术的健康品牌， 广东浠芮生物科技有限责任公司旗下健康管理品牌燕教授不仅推出了广受好评的后生元植萃牙膏等口腔 护理系列，更将这一前沿理念从"口腔微生态"拓展至肠道健康、体重管理与内服抗衰全场景，真正实 现"由口入身"的健康闭环。 而2025年6月重磅上市的全新产品——燕教授后生元闪释粉，正是这一战略的关键落子。 便捷营养补充： ...

Core Insights - Quaker has launched China's first fermented oat product, utilizing specialized fermentation technology to enhance gut health for consumers [1][3] Group 1: Product Development - The new product incorporates fermented oat powder, which has been developed over three years, enhancing nutritional absorption by breaking down large molecules into smaller, more absorbable active substances [3] - The fermentation process introduces five selected probiotics, resulting in beneficial metabolites known as postbiotics, which work alongside prebiotics found in oats to promote gut health [3][4] Group 2: Health Benefits - A 30-day human trial conducted in collaboration with Southeast University showed significant improvements in gut comfort, beneficial gut bacteria, and immune inflammatory factors among participants [4] - The combination of oat prebiotics and fermented postbiotics in the product, branded as "Quaker Super Fiber Q," aims to enhance gut health and self-care capabilities [4] Group 3: Market Positioning - Quaker's new product is positioned to address the common gut health issues faced by over 80% of Chinese consumers, such as abdominal pain, bloating, and constipation, which are often not widely recognized [5] - The product is designed to meet the increasing demand for functional and health-oriented food options among Chinese consumers, who seek to improve their dietary habits [5] Group 4: Brand Strategy - Quaker is launching a "30 Days to Rebalance" challenge on social media to encourage consumers to improve their gut health through consistent consumption of the new fermented oat product [5] - The brand's new mission reflects a commitment to bridging traditional dietary wisdom with modern consumer needs, aiming to provide balanced nutrition for various life stages [6]

Core Insights - The National Dairy Technology Innovation Center held its third annual conference focusing on technological advancements in the dairy industry, showcasing the latest progress and industrialization achievements in dairy technology [1][2] - The "Postbiotics White Paper" was jointly released, providing authoritative guidance for understanding postbiotics and serving as a critical decision-making tool for R&D and market strategies for companies in the industry [1][2][3] Industry Overview - Postbiotics, defined as non-viable microorganisms and their metabolites, are rapidly gaining traction in the global health food and supplement market, with a projected market size growth from $1.2 billion in 2024 to $4.5 billion by 2031, reflecting a compound annual growth rate (CAGR) of 21.3% [2] - China has made significant progress in postbiotic research, achieving initial results in areas such as gut microbiota regulation, immune enhancement, skin health, and infant nutrition [2] Challenges and Initiatives - The industry faces challenges in the research and industrialization of postbiotics, including a lack of unified definitions and classifications, unclear mechanisms of action, absence of relevant standards, and difficulties in technology transfer [2] - The National Dairy Technology Innovation Center initiated a special technology project in 2022 to systematically advance the field of postbiotics, integrating resources from academia and industry to promote scientific standards and industrial innovation [2] Product Development and Innovation - The conference highlighted the release of the "Postbiotics White Paper," which systematically outlines the scientific connotations, efficacy components, and health effects of postbiotics, focusing on representative strains such as Lactobacillus casei ET-22 and Bifidobacterium longum infantis YLGB-1496 [3] - Jin Qi Biological showcased its evidence-based postbiotic products, including Lactobacillus casei ET-22, which has undergone extensive clinical trials demonstrating its efficacy in oral health [7][10] Company Strategy and Future Plans - Jin Qi Biological has developed a complete industrial chain system for functional probiotics, from strain selection to market production, and aims to leverage global resources from partners like Yili and Ausnutria to enhance its offerings in the health sector [11]

Core Insights - The beverage industry is increasingly integrating probiotics into their products, with brands like Luckin Coffee and Nayuki Tea launching probiotic drinks at competitive prices, attracting consumer interest [1][3][4] - The trend of adding probiotics to beverages is not new, but it has evolved from simple yogurt drinks to more sophisticated formulations, enhancing consumer experience and product efficiency [4][7] - The probiotic market in China is experiencing significant growth, with a projected annual growth rate of 11% to 12%, potentially reaching a market size of 137.7 billion yuan by 2026 [12][13] Group 1: Probiotic Beverage Innovations - Recent launches include Luckin's probiotic American coffee and Nayuki's probiotic milkshake, which sold over 500,000 cups in just three days [1][4] - The introduction of instant probiotics in drinks, such as Tea Yan Yue Se's probiotic iced drinks, showcases the industry's shift towards more convenient and innovative product offerings [5][8] - The combination of ready-to-drink tea and probiotics is appealing to consumers, providing a healthier image for traditional beverages [8] Group 2: Market Dynamics and Consumer Trends - The probiotic beverage segment is gaining traction, with major dairy brands like Yili and Mengniu investing in probiotic products, indicating a shift in consumer preferences towards health-oriented options [9][10] - Probiotic dairy products accounted for 36.9% of the probiotic market share, with sales reaching 710 million yuan in Q1 2024, reflecting a growing consumer demand [10] - A significant portion of the Chinese population, 87.6%, experiences gut health issues, leading to increased interest in probiotic solutions [13][14] Group 3: Future Growth Opportunities - The ongoing innovation in probiotic beverages is expected to create new growth points, as consumers seek healthier lifestyle choices [22] - The industry is moving towards a more health-conscious approach, with products incorporating not just probiotics but also prebiotics and other functional ingredients [19][21] - The global probiotic beverage market is projected to grow significantly, with an expected market size of approximately $40.1 billion by 2025, indicating a robust demand for these products [19]

撰文丨王朝 编辑丨王多鱼 排版丨水成文 慢性便秘 是一种常见的胃肠道疾病，常伴有肠道炎症，对患者的生活质量影响很大。治疗通常包括饮食调 整、排便习惯教育以及使用非处方泻药。尽管泻药容易获取，但它们常常会引起肠胃不适，近半数患者对 此表示不满。 2025 年 4 月 25 日，内蒙古农业大学张和平教授团队联合多家医疗机构，在 Cell 子刊 Cell Reports Medicine 上发表了题为： Efficacy of a postbiotic and its components in promoting colonic transit and alleviating chronic constipation in humans and mice 的研究论文。 这项突破性研究揭示了 后生元制剂 Probio-Eco 通过调控" 肠道菌群-代谢物 "双通路，显著改善慢性便秘 。 这项历时 2 年、覆盖 110 人的临床试验，或将改写全球 6 亿便秘人群的治疗方式！ Cell Reports Medicine Article Efficacy of a postbiotic and its component ...